Heart failure with reduced ejection fraction due to dilated cardiomyopathy

Heart failure with reduced ejection fraction due to dilated cardiomyopathy is a clinical cardiovascular syndrome characterized by the heart's inability to maintain adequate systemic perfusion Patients present with symptoms of systemic hypoperfusion and pulmonary or peripheral venous congestion, including exertional dyspnea, fatigue, orthopnea, and peripheral edema

Heart failure with reduced ejection fraction due to dilated cardiomyopathy is a clinical cardiovascular syndrome characterized by the heart's inability to maintain adequate systemic perfusion Pathophysiologically, the disease is marked by progressive structural remodeling involving left or biventricular chamber dilatation, wall thinning, and severely impaired contractile performance that reduces left ventricular ejection fraction to 40 percent or lower

It develops when genetic mutations, toxic exposures, inflammatory conditions, or idiopathic processes lead to non-ischemic myocardial damage Pathophysiologically, the disease is marked by progressive structural remodeling involving left or biventricular chamber dilatation, wall thinning, and severely impaired contractile performance that reduces left ventricular ejection fraction to 40 percent or lower

It develops when genetic mutations, toxic exposures, inflammatory conditions, or idiopathic processes lead to non-ischemic myocardial damage

It develops when genetic mutations, toxic exposures, inflammatory conditions, or idiopathic processes lead to non-ischemic myocardial damage Patients present with symptoms of systemic hypoperfusion and pulmonary or peripheral venous congestion, including exertional dyspnea, fatigue, orthopnea, and peripheral edema

It develops when genetic mutations, toxic exposures, inflammatory conditions, or idiopathic processes lead to non-ischemic myocardial damage

Pathophysiologically, the disease is marked by progressive structural remodeling involving left or biventricular chamber dilatation, wall thinning, and severely impaired contractile performance that reduces left ventricular ejection fraction to 40 percent or lower

Patients present with symptoms of systemic hypoperfusion and pulmonary or peripheral venous congestion, including exertional dyspnea, fatigue, orthopnea, and peripheral edema